9 pending office actions • 6 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (11%) |
| §101 + other | 1 (11%) |
| §112 only | 2 (22%) |
| Multi-statute (no §101) | 5 (56%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WANG, RUIXUE | 1 | 57.4% | +22.1% |
| POLLOCK, AUSTIN M | 1 | 51.7% | +36.5% |
| NIEBAUER, RONALD T | 1 | 41.0% | +33.6% |
| BAUER, NICOLA MARIA | 1 | 56.6% | +47.4% |
| REYNOLDS, FRED H | 1 | 33.1% | +39.0% |
| SIMMONS, VALERIE MICHELLE | 1 | 30.2% | +50.5% |
| MONTES, NARCISO EDUARDO | 1 | 57.1% | +0.0% |
| KINSEY WHITE, NICOLE ERIN | 1 | 58.0% | +16.2% |
| GIAMMONA, FRANCESCA FILIPPA | 1 | 37.0% | +55.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18350803 | PEPTIDE DISINFECTANT FOR PREVENTING CORONAVIRUSES | NIEBAUER, RONALD T | 60d |
| 18292538 | GENERAL AFFINITY EPITOPE POLYPEPTIDE FOR HUMAN RHINOVIRUS, AND ANTIBODY AND USES THEREOF | WANG, RUIXUE | — |
| 18449932 | COMPOSITE METAL MATERIAL AND LOW-TEMPERATURE SOLDER PASTE WITH HIGH THERMAL CONDUCTIVITY CONTAINING SAME | POLLOCK, AUSTIN M | — |
| 18349434 | TRIPHENYPHOSPHINE MODIFIED SERTRALINE DERIVATIVE AND METHODS THEREOF | BAUER, NICOLA MARIA | — |
| 18143920 | METHOD FOR TWO-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE DIFFUSION ORDERED SPECTROSCOPY BASED ON DEEP LEARNING | MONTES, NARCISO EDUARDO | — |
| 17997465 | DETECTION REAGENT FOR SCREENING BLOCKING AGENT OF CORONAVIRUS INFECTIONS, AND DETECTION METHOD | KINSEY WHITE, NICOLE ERIN | — |
| 17757986 | METHOD FOR ASYMMETRIC AMPLIFICATION OF TARGET NUCLEIC ACID | GIAMMONA, FRANCESCA FILIPPA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18350803 | PEPTIDE DISINFECTANT FOR PREVENTING CORONAVIRUSES | NIEBAUER, RONALD T | 60d |
| 18337091 | PREPAKAGED POLYMERASE CHAIN REACTION (PCR) REAGENT FOR NUCLEIC ACID AMPLIFICATION AND METHOD THEREOF | REYNOLDS, FRED H | 70d |
| 18267586 | FLUORESCENCE ANALYSIS METHOD FOR LITHIUM ION DETERMINATION USING FREE-BASE PHTHALOCYANINE (FBPc) AS MOLECULAR PROBE | SIMMONS, VALERIE MICHELLE | 71d |
| 18292538 | GENERAL AFFINITY EPITOPE POLYPEPTIDE FOR HUMAN RHINOVIRUS, AND ANTIBODY AND USES THEREOF | WANG, RUIXUE | — |
| 18449932 | COMPOSITE METAL MATERIAL AND LOW-TEMPERATURE SOLDER PASTE WITH HIGH THERMAL CONDUCTIVITY CONTAINING SAME | POLLOCK, AUSTIN M | — |
| 18349434 | TRIPHENYPHOSPHINE MODIFIED SERTRALINE DERIVATIVE AND METHODS THEREOF | BAUER, NICOLA MARIA | — |
| 17997465 | DETECTION REAGENT FOR SCREENING BLOCKING AGENT OF CORONAVIRUS INFECTIONS, AND DETECTION METHOD | KINSEY WHITE, NICOLE ERIN | — |
| 17757986 | METHOD FOR ASYMMETRIC AMPLIFICATION OF TARGET NUCLEIC ACID | GIAMMONA, FRANCESCA FILIPPA | — |
| Art Unit | Apps |
|---|---|
| 1672 | 2 |
| 1658 | 2 |
| 1738 | 1 |
| 1621 | 1 |
| 1758 | 1 |
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18292538 | GENERAL AFFINITY EPITOPE POLYPEPTIDE FOR HUMAN RHINOVIRUS, AND ANTIBODY AND USES THEREOF | WANG, RUIXUE | 1672 | §103§112 | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18449932 | COMPOSITE METAL MATERIAL AND LOW-TEMPERATURE SOLDER PASTE WITH HIGH THERMAL CONDUCTIVITY CONTAINING SAME | POLLOCK, AUSTIN M | 1738 | §102§103 | Final Rejection | — | Pending | Aug 15, 2023 |
| 18350803 | PEPTIDE DISINFECTANT FOR PREVENTING CORONAVIRUSES | NIEBAUER, RONALD T | 1658 | §101§102§112 | Non-Final OA | 60d | Pending | Jul 12, 2023 |
| 18349434 | TRIPHENYPHOSPHINE MODIFIED SERTRALINE DERIVATIVE AND METHODS THEREOF | BAUER, NICOLA MARIA | 1621 | §103§112 | Non-Final OA | — | Pending | Jul 10, 2023 |
| 18337091 | PREPAKAGED POLYMERASE CHAIN REACTION (PCR) REAGENT FOR NUCLEIC ACID AMPLIFICATION AND METHOD THEREOF | REYNOLDS, FRED H | 1658 | §112 | Final Rejection | 70d | Pending | Jun 19, 2023 |
| 18267586 | FLUORESCENCE ANALYSIS METHOD FOR LITHIUM ION DETERMINATION USING FREE-BASE PHTHALOCYANINE (FBPc) AS MOLECULAR PROBE | SIMMONS, VALERIE MICHELLE | 1758 | §112 | Non-Final OA | 71d | Pending | Jun 15, 2023 |
| 18143920 | METHOD FOR TWO-DIMENSIONAL NUCLEAR MAGNETIC RESONANCE DIFFUSION ORDERED SPECTROSCOPY BASED ON DEEP LEARNING | MONTES, NARCISO EDUARDO | — | §101 | Non-Final OA | — | Pending | May 05, 2023 |
| 17997465 | DETECTION REAGENT FOR SCREENING BLOCKING AGENT OF CORONAVIRUS INFECTIONS, AND DETECTION METHOD | KINSEY WHITE, NICOLE ERIN | 1672 | §103§112 | Final Rejection | — | Pending | Oct 28, 2022 |
| 17757986 | METHOD FOR ASYMMETRIC AMPLIFICATION OF TARGET NUCLEIC ACID | GIAMMONA, FRANCESCA FILIPPA | 1681 | §102§103 | Non-Final OA | — | Pending | Jun 24, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial